148 related articles for article (PubMed ID: 23594240)
1. Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy.
Woo VG; Liegler T; Cohen CR; Sawaya GF; Smith-McCune K; Bukusi EA; Huchko MJ
AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1000-5. PubMed ID: 23594240
[TBL] [Abstract][Full Text] [Related]
2. Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.
Huchko MJ; Woo VG; Liegler T; Leslie H; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR
BJOG; 2013 Sep; 120(10):1233-9. PubMed ID: 23647852
[TBL] [Abstract][Full Text] [Related]
3. Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy?
Huchko MJ; Woo V; Liegler T; Leddy A; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR
J Low Genit Tract Dis; 2013 Jul; 17(3):354-60. PubMed ID: 23486070
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso.
Nagot N; Ouedraogo A; Weiss HA; Konate I; Sanon A; Defer MC; Sawadogo A; Andonaba JB; Vallo R; Becquart P; Segondy M; Mayaud P; Van de Perre P;
Sex Transm Infect; 2008 Jun; 84(3):167-70. PubMed ID: 18055582
[TBL] [Abstract][Full Text] [Related]
5. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.
Neely MN; Benning L; Xu J; Strickler HD; Greenblatt RM; Minkoff H; Young M; Bremer J; Levine AM; Kovacs A
J Acquir Immune Defic Syndr; 2007 Jan; 44(1):38-42. PubMed ID: 17106279
[TBL] [Abstract][Full Text] [Related]
6. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
[TBL] [Abstract][Full Text] [Related]
7. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
Cu-Uvin S; DeLong AK; Venkatesh KK; Hogan JW; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM
AIDS; 2010 Oct; 24(16):2489-97. PubMed ID: 20736815
[TBL] [Abstract][Full Text] [Related]
8. Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.
Gitau RW; Graham SM; Masese LN; Overbaugh J; Chohan V; Peshu N; Richardson BA; Jaoko W; Ndinya-Achola JO; McClelland RS
AIDS; 2010 Nov; 24(17):2733-7. PubMed ID: 20871388
[TBL] [Abstract][Full Text] [Related]
9. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.
Homans J; Christensen S; Stiller T; Wang CH; Mack W; Anastos K; Minkoff H; Young M; Greenblatt R; Cohen M; Strickler H; Karim R; Spencer LY; Operskalski E; Frederick T; Kovacs A
J Acquir Immune Defic Syndr; 2012 May; 60(1):99-110. PubMed ID: 22517416
[TBL] [Abstract][Full Text] [Related]
10. Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.
Venkatesh KK; DeLong AK; Kantor R; Chapman S; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM; Cu-Uvin S
J Womens Health (Larchmt); 2013 Apr; 22(4):330-8. PubMed ID: 23531097
[TBL] [Abstract][Full Text] [Related]
11. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
[TBL] [Abstract][Full Text] [Related]
12. Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy.
Graham SM; Masese L; Gitau R; Richardson BA; Mandaliya K; Peshu N; Jaoko W; Ndinya-Achola J; Overbaugh J; McClelland RS
Sex Transm Infect; 2011 Mar; 87(2):114-7. PubMed ID: 20980464
[TBL] [Abstract][Full Text] [Related]
13. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.
Low AJ; Konate I; Nagot N; Weiss HA; Kania D; Vickerman P; Segondy M; Mabey D; Pillay D; Meda N; van de Perre P; Mayaud P;
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):237-45. PubMed ID: 24226060
[TBL] [Abstract][Full Text] [Related]
14. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.
Graham SM; Holte SE; Peshu NM; Richardson BA; Panteleeff DD; Jaoko WG; Ndinya-Achola JO; Mandaliya KN; Overbaugh JM; McClelland RS
AIDS; 2007 Feb; 21(4):501-7. PubMed ID: 17301569
[TBL] [Abstract][Full Text] [Related]
15. Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-adherent women.
Henning TR; Kissinger P; Lacour N; Meyaski-Schluter M; Clark R; Amedee AM
J Infect Dis; 2010 Nov; 202(10):1543-52. PubMed ID: 20925530
[TBL] [Abstract][Full Text] [Related]
16. Cervical intraepithelial neoplasia and cervicovaginal shedding of human immunodeficiency virus.
Spinillo A; Zara F; Gardella B; Preti E; Gaia G; Maserati R
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):314-20. PubMed ID: 16449118
[TBL] [Abstract][Full Text] [Related]
17. Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.
Ondoa P; Gautam R; Rusine J; Lutter R; Jurriaans S; Kootstra N; Karita E; van de Wijgert J
PLoS One; 2015; 10(5):e0127201. PubMed ID: 26010956
[TBL] [Abstract][Full Text] [Related]
18. Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study.
Launay O; Tod M; Tschöpe I; Si-Mohamed A; Bélarbi L; Charpentier C; Goujard C; Taburet AM; Lortholary O; Leroy V; Bélec L;
Antivir Ther; 2011; 16(6):843-52. PubMed ID: 21900716
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
[TBL] [Abstract][Full Text] [Related]
20. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
